Presented by ValueWalk
Johnson Johnson announced the recall of five aerosol sunscreens from. at Neutrogena Yes Aveeno after small traces of benzene were found in some product samples. The substance is known to cause cancer.
Because aerosol sunscreens were sold in stores in the United States, the company encouraged customers to stop using the products.
Benzene is not an ingredient
As of the. reported New York Post, plus spray sunscreen Aveeno Protect + Refresh, four Neutrogena sunscreens are involved in the recall: Sunscreen Spray Beach defense, Spray on sunscreen CoolDry Sport, Spray on sunscreen Invisible daily defense and spray on sunscreen Ultra sheer.
According to the Centers for Disease Control and Prevention (CDC), benzene has long been linked to leukemia and other cancers when a person is exposed to large amounts for long periods of time.
While JJ determined that benzene was not a part of the sunscreens concerned, the company is investigating how the substance could be linked to the products listed above.
The company issued a statement on Wednesday stating that “daily exposure to benzene in these aerosol sunscreen products at the levels found in our tests is not expected to have adverse health effects.”
“As a precaution, we are recalling all lots of these special aerosol sunscreen products.”
- To Learn More: FDA Warns Guillain-Barré Syndrome May Be Linked to Johnson Johnson Vaccine
Another blow to the company in a couple of years
JJ has stated that the recall of the products is voluntary and that it has “notified the Food and Drug Administration”. Meanwhile, the company said, “It is working to get all batches of the five products off the shelves across the country.”
Over the past few years, J J’s reputation has been marred by thousands of lawsuits against its famous talc-based baby powder. In January, the US Supreme Court declined to overturn a ruling requiring the company to pay 22 women a whopping $ 2 billion for cancer cases related to the asbestos in the product.
“Last year the company stopped selling the product and recently saved $ 3.9 billion to cover the cost of the litigation.”
As reported by CNN, the FDA also updated Johnson Johnson’s vaccine label on Monday “to warn of the possible increased risk of a rare neurological complication known as Guillain-Barré syndrome (GBS).”